Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis-Reference-Cited by-同舟云学术

Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis

Published:2020-01 Issue:4 Volume:99 Page:e18890
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Asano Tomoyuki,Sato Shuzo,Temmoku Jumpei,Fujita Yuya,Furuya Makiko Yashiro,Matsuoka Naoki,Kobayashi Hiroko,Suzuki Eiji,Watanabe Hiroshi,Migita Kiyoshi

Funder

Japan Society for the Promotion of Science

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Takayasu arteritis--advances in diagnosis and management;Mason;Nat Rev Rheumatol,2010

2. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients;Maksimowicz-McKinnon;Arthritis Rheum,2007

3. Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies;Clifford;Curr Opin Rheumatol,2014

4. Takayasu's arteritis;Pariser;Curr Opin Cardiol,1994

5. Biologic treatment of large-vessel vasculitides;Schäfer;Curr Opin Rheumatol,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl;Modern Rheumatology Case Reports;2022-08-26

2. An Update on Childhood-Onset Takayasu Arteritis;Frontiers in Pediatrics;2022-04-13

3. Takayasu-Arteriitis bei Kindern und Jugendlichen;Pädiatrische Rheumatologie;2022

4. Takayasu-Arteriitis bei Kindern und Jugendlichen;Pädiatrische Rheumatologie;2021